期刊
BIOTECHNIQUES
卷 69, 期 5, 页码 357-+出版社
FUTURE SCI LTD
DOI: 10.2144/btn-2020-0059
关键词
antibiotics; anticancer drugs; decatenation; gyrase; topoisomerase
资金
- Biotechnology and Biosciences Research Council (UK) Institute Strategic Programme Grant [BB/P012523/1]
- Wellcome Trust [110072/Z/15/Z]
- BBSRC-CASE studentship - Inspiralis Ltd. [BB/M011216/1]
- Leverhulme Trust [RP2013-K-017]
- BBSRC [1805532] Funding Source: UKRI
- Wellcome Trust [110072/Z/15/Z] Funding Source: Wellcome Trust
METHOD SUMMARY We engineered a plasmid such that reaction with Tn3resolvase generates a singly-linked catenane product. Restriction enzyme digestion and caesium chloride density gradient centrifugation enable the purification of the catenane product substantially free from starting plasmid. This product may be utilized in topoisomerase enzyme assays. Decatenation is a crucialin vivoreaction of DNA topoisomerases in DNA replication and is frequently used inin vitrodrug screening. Usually this reaction is monitored using kinetoplast DNA as a substrate, although this assay has several limitations. Here we have engineered a substrate for Tn3resolvase that generates a singly-linked catenane that can readily be purified from the DNA substrate after restriction enzyme digestion and centrifugation. We show that this catenated substrate can be used with high sensitivity in topoisomerase assays and drug-inhibition assays.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据